TFA
ALDX icon

Tobias Financial Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Tobias Financial Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,695
Closed -$118K – 114
2024
Q4 		$118K Hold
23,695
– – 0.02% 110
2024
Q3 		$128K Hold
23,695
– – 0.03% 105
2024
Q2 		$78.4K Sell
23,695
-4,478
-16% -$17.5K 0.02% 101
2024
Q1 		$92.1K Sell
28,173
-3,000
-10% -$9.87K 0.02% 99
2023
Q4 		$109K Sell
31,173
-3,000
-9% -$9.26K 0.03% 94
2023
Q3 		$228K Hold
34,173
– – 0.06% 82
2023
Q2 		$287K Hold
34,173
– – 0.08% 75
2023
Q1 		$339K Hold
34,173
– – 0.1% 67
2022
Q4 		$238K Hold
34,173
– – 0.08% 72
2022
Q3 		$182K Hold
34,173
– – 0.06% 75
2022
Q2 		$136K Hold
34,173
– – 0.05% 76
2022
Q1 		$152K Buy
+34,173
New +$136K 0.05% 66
2021
Q4 		– Sell
-34,173
Closed -$300K – 70
2021
Q3 		$300K Hold
34,173
– – 0.11% 58
2021
Q2 		$387K Hold
34,173
– – 0.15% 54
2021
Q1 		$406K Hold
34,173
– – 0.17% 51
2020
Q4 		$234K Hold
34,173
– – 0.11% 56
2020
Q3 		$253K Hold
34,173
– – 0.14% 56
2020
Q2 		$143K Hold
34,173
– – 0.08% 57
2020
Q1 		$84K Buy
+34,173
New +$154K 0.06% 54

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Tobias Financial Advisors's ALDX Position: Q1 2025 in Review

Tobias Financial Advisors sold out of Aldeyra Therapeutics (ALDX) in Q1 2025, closing a stake of 23,695 shares — an estimated $118K sold.

Tobias Financial Advisors first reported a position in ALDX in Q1 2020 and held it in 19 quarters. The position peaked at $406K in Q1 2021. 125 funds tracked by Wall St. Rank hold ALDX as of Q1 2025.

  • Tobias Financial Advisors reported no remaining Aldeyra Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Tobias Financial Advisors sold 23,695 Aldeyra Therapeutics shares in Q1 2025, an estimated $118K.
  • Tobias Financial Advisors first reported a position in Aldeyra Therapeutics in Q1 2020 and held it in 19 quarters.
  • Tobias Financial Advisors's Aldeyra Therapeutics position peaked at $406K in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2025.

Based on Tobias Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.